Alcohol
What would you like to know about alcohol?
"alcohol" AND "health effects"
alcohol health effects risks 2025 WHO evidence

Fatty liver (reversible) → Alcoholic hepatitis → Cirrhosis → Liver failure
| System | Key Harms |
|---|---|
| Liver | Fatty liver → hepatitis → cirrhosis → liver failure |
| Nervous system | Dementia, Wernicke/Korsakoff, neuropathy, cerebellar degeneration |
| Cardiovascular | Cardiomyopathy, hypertension, atrial fibrillation |
| Cancer | Head/neck, oesophagus, liver, colorectum, breast, stomach, pancreas |
| GI tract | Pancreatitis, gastritis, malabsorption, vitamin deficiencies |
| Endocrine | Hypoglycaemia, sex hormone disruption, electrolyte imbalance |
| Blood | Anaemia (folate/iron), haemolysis, bone marrow suppression |
| Immune | Increased infection risk (pneumonia, TB) |
| Fetus | Fetal alcohol syndrome, intellectual disability, malformations |
Sprain
"sprain" AND "ligament injury" AND management
sprain definition classification grading treatment 2025
"ankle sprain" AND rehabilitation
| Grade | Ligament Damage | Signs & Symptoms | Weight Bearing |
|---|---|---|---|
| I | Microscopic tears only; ligament intact | Tenderness, minimal swelling, no laxity | Possible with minimal pain |
| II | Partial tear | Moderate swelling, ecchymosis, some pain, little or no instability | Difficult |
| III | Complete rupture | Severe swelling, prominent ecchymosis, no endpoint on stress testing | Usually impossible |
Joint stability - not just pain - is the primary determinant of treatment planning.
Protection - Rest - Ice - Compression - Elevation
If ankle pain becomes chronic after a sprain, always consider ligament rupture, osteochondral lesion, or avulsion fracture, and proceed with CT (bony) or MRI (soft tissue) imaging.
| Feature | Sprain | Strain |
|---|---|---|
| Structure injured | Ligament (bone-to-bone) | Muscle or tendon (muscle-to-bone) |
| Mechanism | Joint overstretched/twisted | Muscle overloaded or overstretched |
| Common sites | Ankle, knee, wrist, thumb | Hamstring, quadriceps, calf, lower back |
| Stress test | Often positive (laxity) | Negative (no joint laxity) |
Zero order kinetics
zero order kinetics pharmacology drug elimination clinical significance
| Zero-Order | First-Order | |
|---|---|---|
| Rate equation | dA/dt = -k₀ | dA/dt = -k₁ · A(t) |
| Rate constant units | mass/time (e.g. mg/min) | reciprocal time (e.g. min⁻¹) |
| Concentration over time | Decreases linearly | Decreases exponentially |
| Half-life | Not constant - changes as concentration changes | Constant |
| Plasma level vs. dose graph | Exponentially steep (nonlinear) | Straight line (linear) |
v = (Vmax × [C]) / (Km + [C])


A small dose increase in a zero-order drug can cause a disproportionately large rise in plasma concentration, rapidly pushing into the toxic range.

| Feature | Impact |
|---|---|
| No true "half-life" | Impossible to predict when drug will be cleared |
| Accumulation risk | Drug builds up faster than expected with dose increases |
| Narrow therapeutic index | Small errors in dosing cause toxicity |
| Monitoring required | Plasma levels must be checked; population averages do not apply |
| Disproportionate toxicity | Doubling the dose can more than double the plasma level |
| Property | Zero-Order | First-Order |
|---|---|---|
| Rate depends on concentration? | No | Yes |
| Amount eliminated per unit time | Constant (fixed mg/hr) | Variable (proportional to level) |
| Plasma-time curve | Straight line (arithmetic) | Exponential decay |
| Half-life | Variable (not useful) | Constant |
| Dose-concentration relationship | Nonlinear (exponential) | Linear |
| Mechanism | Enzyme/transporter saturation | Unsaturated enzymatic metabolism |
| Examples | Ethanol, phenytoin (high dose), aspirin (high dose) | Most drugs at therapeutic levels |